December 20, 2024

POI Guidelines See First Major Update Since 2015

Four medical societies have revised their diagnostic criteria for premature ovarian insufficiency, now requiring only one elevated FSH test instead of two, while reporting a higher than previously known prevalence rate of 3.5% among women.

Conexiant

December 17, 2024

Trump's Health Picks Clash on Vaccines, Policy

The selection of individuals for federal health agencies under President-elect Donald Trump presents conflicting views on matters such as abortion limits, vaccine safety, covid-19 responses, and the use of weight-loss medications.

KFF Health News

December 16, 2024

Study Finds New Sexual Transmission Disease Risks

Review expands list of viruses persisting in human semen from 9 to 22.

Conexiant

December 16, 2024

Reproductive Guidelines Shift on Surgical Timing

The ASRM issued updated guidelines for diagnosing and treating uterine septum, stressing shared decision-making and the use of three-dimensional transvaginal ultrasound as a first-line diagnostic tool.

Conexiant

December 16, 2024

Birth Timing Impacts Lifetime Suicide Risk

In a large Nordic cohort study of nearly 7 million individuals, women born very preterm showed a 76% higher risk of suicide mortality compared to full-term peers, while preterm birth showed no association with suicide risk in men, suggesting a possible sex-specific vulnerability that warrants clinical attention.

Conexiant

December 16, 2024

Weight-Loss Drugs Spark Health Care Shift

An exclusive analysis reveals the impact of weight-loss drugs on obesity-related conditions, leading to increased diagnoses of sleep apnea, cardiovascular disease, and type 2 diabetes within days of treatment initiation.

Reuters

December 16, 2024

Could Elagolix Replace Painful IVF Injectables?

New research compares oral elagolix with injectable medications for ovulation suppression during in vitro fertilization, showing comparable clinical outcomes and higher suppression of the hypothalamic-pituitary axis.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 11, 2024

Sex Differences in Statin-Linked Diabetes Risk

Study finds women are nearly twice as likely as men to report statin-associated diabetes mellitus, with atorvastatin showing the highest reporting disparity, according to Food and Drug Administration’s Adverse Event Reporting System data.

Conexiant